Drug factory · FDA FEI 3003877289
Shandong Anhong Pharmaceutical Co., Ltd.
No. 29 Huayuan Street Linyi County, Dezhou, China
Serious problems, FDA action at FDA's last inspection, Jun 26, 2026.
Official Action Indicated: inspectors found significant problems and FDA recommended regulatory action, such as a warning letter or import alert.
4 drug inspections on record since 2013: 1 with no problems, 2 with problems fixed voluntarily, 1 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Tenofovir | Makes the active ingredient and packages it | Florida Pharmaceutical Products, LLC., Qilu Pharmaceutical Co., Ltd. | 69076-105, 71921-105, 67184-0519 +2 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jun 26, 2026 | Serious problems, FDA action | Drug Quality Assurance | — |
| Feb 22, 2019 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Sep 2, 2016 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Sep 13, 2013 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture; label; manufacture; pack.